Anti Alcohol Drugs

Low-dose naltrexone (LDN) has been demonstrated to reduce symptom severity in conditions such as fibromyalgia, Crohn’s disease, multiple sclerosis, and complex regional pain syndrome. We review the evidence that LDN may operate as a novel anti-inflammatory agent in the central nervous system, via action on microglial cells. These effects may be unique to low dosages of naltrexone and appear to be entirely independent from naltrexone’s better-known activity on opioid receptors. As a daily oral therapy, LDN is inexpensive and well-tolerated. Despite initial promise of efficacy, the use of LDN for chronic disorders is still highly experimental. Published trials have low sample sizes, and few replications have been performed. We cover the typical usage of LDN in clinical trials, caveats to using the medication, and recommendations for future research and clinical work. LDN may represent one of the first glial cell modulators to be used for the management of chronic pain disorders.

SMOKING KILLS
Smoking is the major cause of Lung cancer and other disease worldwide. To overcome the ill effect of smoking Derma Medicine Point is supplying quality Nicotine chewing gums to its clients worldwide.
Nicotex Chewing Gum  contains Nicotine Polacrilex. Known for providing the partial substitution for nicotine in smoke, the offered product is widely considered for Tobacco deaddiction.
Features:

• Partial substitution for nicotine
• Contains nicotine polacrilex as an active ingredient
• Used as an aid for smoking cessation therapy